Manuel Henriquez
Analyst · JMP
Thanks Scott, and good afternoon and thank you everyone for joining us today. I will start the call as usual by providing a quick summary of our operating results and achievements, and then follow by a few observations and discussion points on the environment as a whole and then the venture industry and the impact that we are seeing manifest itself in the investment industry to our portfolio. That said, we completed and executed a very strong third quarter in spite of a very weak and very, very frustrating July period of time where we saw an amazing decline in activities in July and August on both new business as we as we saw manifest itself in the public markets with lack of trading. Notwithstanding that, we actually generated for our shareholders, $8.1 million in net investment income or GAAP earnings of approximately $0.23 per share which I think at last estimate is $0.01 above the street consensus on our performance. In addition to that, starting in Q3 of this year, we’re going to start reporting DNOI which was approximately $0.25 per share, of which David Lund, our CFO to kind of expand upon the DNOI reporting – I apologize, it’s a new word for me – to report on. In terms of total commitments, despite a fairly soft Q3 and something that we have forewarned previously, the quarter was actually not a bad quarter. It was completed with $83 million of new commitments were executed in the quarter of which $55 million were to new companies and the balance existing companies which we renewed or restructured credit facilities. Beyond that, we saw approximately $44 million of funding – excuse me, my mistake. We are seeing a very good momentum in Q4 as we now have seen $44 million, pardon me, of commitments that we have closed in the first month of the fourth quarter and the issue with that and why I’m raising it is that part of those transactions closed in the first week of October, and we are seeing at least in the third quarter, a longer delay in getting transactions closed that we had forecasted and anticipated closing in the third quarter, which basically closed in the first week or so of October, representing $44 million. Beyond that, we have approximately $100 million of signed term sheets leading into Q4 and we have a pipeline that is now exceeding $1 billion and giving us very strong visibility to Q4 and Q1 and beyond in terms of closing new commitments. But I have to once again give attention to this statement. Commitments do not necessarily reflect funding. It is frustrating for us because we cannot control the actual amount and date of fundings, but that is evidenced on our continuing building backlog you’ll see us report here every quarter, which is called the unfunded commitments that we talked about. More importantly, we just achieved a significant milestone. Since going public, we have now reached and exceed a total of $2 billion in committed capital to venture stage and life sciences companies and technology life sciences industry. Personally, it’s a very proud achievement and now we see over 150 companies and that would not have been done without the extremely hard work and dedication of all the employees at Hercules Technology who have worked diligently to perform very, very hard to realized these $2 billion numbers, but more importantly than the $2 billion achievement is the credit performance by which that was done. We achieved over $2 billion of commitments to Technology Life Science companies with only $42 million in total losses net during our six year period of time, which of course, I’ll let David Lund, our CFO, provide a bit more color on that as well. In terms of our assets, we finished the quarter at approximately $408 million in assets, slightly down from that of the third quarter, and as I said earlier, that was primarily driven by early pay offs that took place at the end of the quarter, and most of those assets have already been recouped in terms of new investments leading into the fourth quarter as we look forward. In addition to that, we successfully received the ability to lock in our SBIC debentures at an interest rate of 3.215 on $25 million of capital. This affords us a very strong visibility to having locked in costs of capital that are quite accretive in the event that interest rates were to go up in the future. Lastly, on our performance, the Board of Directors have once again declared a $0.20 dividend which as we continue to build our dividend and earnings, it is highly likely that we will see some form of either a dividend at the end of the fourth quarter or potential spillover as we continue to originate assets during the fourth quarter. We will periodically revisit that and make any appropriate announcements to our shareholders on that. I am proud to say that as evidenced in our earnings, we continue to focus on earnings growth, and you’re seeing that manifest itself into that with our EPS of $0.23 in earnings. Now, let’s turn our attention to the venture capital industry. Despite all the media claiming that the venture capital industry is dead, it is far but that. Personally, I saw that the third quarter originations were quite robust. In fact, we were expect to see a number lower than $5.5 billion and we actually saw a number of $5.5 billion take place in Q3 to approximately 660 companies, representing a 2% increase from that of 2009. On a year to date basis, we saw $18 billion of venture capital invested so far in calendar 2010 to over 2,000 companies representing a 10% increase over the same period last year. These are critical factors as we look to the venture industry to continue to show resilience and commitment to deployed capital to various companies in different sectors. Now on sector specific; the largest sector receiving capital continues to be information technology, which received approximately $1.8 billion or up 35% from the same period last year, making it the largest recipient of capital during the third quarter. Life Sciences on the other hand, the second largest category, received $1.7 billion in capital; however, it was down approximately 11% as compared to same time last year, with medical devices making up the lion’s share of that decline, being down 26% over the same period last year. We also saw business services and financial services receive $841 million of capital, up 19% over the same period last year, while consumer services, and even evidence our own portfolio, which we have been declining consumer services, is down 20% to approximately $560 million for the same period last year. And our newest category that we’re now breaking out and reporting, Clean Tech, also known as green technologies received approximately $359 million and although the number is down 20% year on year, it is primarily driven down lower by two large investments that were made in calendar ‘09. Now, no conversation of the venture industry is complete without looking at the totality of the ecosystem, and that means that I’m turning my attention to venture capital exits, also known as liquidity achieved in the venture industry. In the third period, we saw 111 venture capital companies achieve exits totaling $6.4 billion. 102 of those exits were in the form of M&A, representing approximately $5.7 billion, up 5% from the prior year of the same period. Now, the most important part of this statement is IPO’s. Albeit on a historical basis, the IPO activity is still nascent, but when compared to the same period 2005, we basically saw a 500% increase in IPO activity in Q3, 2010 as compared to Q3 ‘09, meaning we saw nine IPO’s go effective in the third quarter raising $723 million. This is up from two IPO events in the same period in 2009. What makes this interesting is that currently today, there are approximately 49 venture stage companies who have unfiled IPO registration statements, five of which, or say it this way, 10% of those are Hercules portfolio companies. We currently have at the end of the third quarter, five companies in registration, one of which was declared effective, Aegerion Pharmaceutical went effective in October giving us a net four companies in IPO registration as of this call today. These are important signs, and encouraging signs. But, let me share with you some insight after my 25 years of doing this business that are important, and I consider very, very critical details on why my optimism is running so high currently. M&A companies are seeing a 20% decline from the first round of venture capital investment in the company through an exit event have declined by 20%. They also saw a 30% increase in more capital to achieve this liquidity event. What is important is, if you look back to what occurred in 1993, ‘95 and ‘99, to draw some historical correlations, the tighter the compression of time to liquidity means that additional capital is needed to differentiate yourself to arbitrage the valuation differential between public coms and that of the private coms. In layman’s terms, you will start seeing a lift in valuations of private companies to start matching the increase in valuations we’re seeing in the public marketplace. This bodes extremely well for our warrant portfolio, but also makes debt a highly sought after asset class because it’s less dilutive for companies to accelerate their windows for liquidity. Conversely, we’re seeing a 60% decline in the time frame for the venture capital dollars invested in a company to a liquidity event, decline by 16% while the capital committed is increasing by 21%. These are actually very, very good signs and very important signs that I look to in the venture industry themselves, and I’m happy to expand those in the Q&A session. Lastly, the environment is not complete until we see the totality of the picture and that is, venture capitalists receiving additional rounds of capital from the limited partners. In Q3, the venture capitalists received approximately $3 billion of capital to 45 funds. This is up 40% from the same period last year. As a whole, for the year to date and Q3, $9.1 billion was invested into new venture capital funds. This data has been provided to us by Dow Jones Venture Source and Thompson Reuters NBCA data. Now in closing, asset quality. Overall, the asset quality remained quite strong during the quarter. Clearly, we had some impairments that we chose to take during the quarter, which we felt was prudent and in keeping with the historical performance of Hercules on one particular asset that so far seems to be improving its performance, but we decided that given what we were seeing, it was prudent to take an impairment to reflect the appropriate carrying value for that asset. Overall, we had the lowest grade five rating we’ve had in quite a long time in the portfolio today, and we’re seeing an improvement in credit quality in the portfolio. On the liquidity situation, remains quite strong. Over $218 million of liquidity we have in the portfolio today, and that is against a growing backlog of approximately $120 million of unfunded commitments followed by the $100 million or so of new signed terms that we received today. With that, I’d like to turn the call over to David Lund, our CFO to continue the conversation, or discussion.